Current Analysis: Hypera SA

Hypera SA is a specialty and generic drug manufacturing company. Over the past year, Hypera’s share price fell about 21% from $8.76 to $6.92 as of Tuesday’s market close.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.